Associated Papers
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants.
Cusato J et al.
Diagnostics (basel, Switzerland), 2023
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients.
Cusato J et al.
The Pharmacogenomics Journal, 2020
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines.
Calcagno A et al.
The Pharmacogenomics Journal, 2016
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
Rodríguez-Nóvoa S et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 2009
Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.
Kiser JJ et al.
Journal of Acquired Immune Deficiency Syndromes (1999), 2008
Select a paper to view details